Effect of Per and Poly-Fluoroalkyl Substances on Pregnancy and Child Development

Thanuja Kilari1, Ankul Singh Suresh1, Rukaiah F Begum1

  • 1Department of Pharmacology, SRM College of Pharmacy, SRMIST, Kattankulathur-603209, Tamil Nadu, India.

Current Pediatric Reviews
|January 12, 2024
PubMed

Insights

Maternal exposure to Per and Poly-Fluoroalkyl Substances (PFAS) during pregnancy is linked to childhood obesity. PFAS disrupt placental health and child development, impacting body mass index and potentially leading to long-term health issues.

Area of Science:

  • Environmental Health
  • Endocrinology
  • Developmental Pediatrics

Background:

  • Maternal exposure to Per and Poly-Fluoroalkyl Substances (PFAS) is a growing concern for child development.
  • PFAS exposure is associated with increased adiposity and potential health risks in children.
  • The precise mechanisms linking maternal PFAS levels to childhood obesity require further elucidation.

Purpose of the Study:

  • To review the effects of Per and Poly-Fluoroalkyl Substances (PFAS) exposure on overweight and obese children.
  • To explore the underlying mechanisms of PFAS action in pregnant women and their offspring.
  • To synthesize current knowledge on the relationship between maternal PFAS concentration and child obesity.

Main Methods:

  • A comprehensive literature review was performed using major scientific databases.
  • The review focused on studies investigating PFAS effects on maternal and child health, including neurological outcomes.
  • Analysis included in vitro and in vivo studies, as well as human epidemiological data.

Main Results:

  • PFAS exposure disrupts placental health and child growth, negatively impacting body mass index.
  • In vitro and in vivo studies demonstrate PFAS-induced adipogenesis and weight gain via PPAR-γ and ER-α activation.
  • Maternal serum PFAS concentrations show a positive correlation with adverse child health outcomes.

Conclusions:

  • PFAS readily cross the placenta, posing a risk to fetal development and long-term child health.
  • Disruption of placental homeostasis by PFAS can lead to adverse pregnancy and child health outcomes.
  • Further research is essential to fully understand the complex implications of PFAS exposure for maternal and child well-being.
Abstract

Related Concept Videos

Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.5K
Halogens03:01

Halogens

Group 17 elements, known as halogens, are nonmetals. At room temperature, fluorine and chlorine are gases, bromine is a liquid, and iodine a solid. Astatine is a highly unstable radioactive element, so currently, most of its properties are unknown due to its short half-life. Tennessine is a synthetic element also predicted to be in this group. 
18.5K
Types of Toxins01:36

Types of Toxins

Humans continually engage with an environment rich in potentially harmful chemicals. These are introduced to our bodies through inhalation, ingestion, or skin contact. These chemicals exist in various forms, such as air and environmental pollutants, agricultural chemicals, organic solvents, and heavy metals.
Air pollutants, primarily gases, pose significant threats to respiratory health, leading to conditions like hypoxia, lung cancer, and in extreme cases, death.
Environmental pollutants like...
1.7K
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics01:23

Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics

Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla.  Benzonatate operates peripherally within the respiratory tract by...
288
Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.3K